Hartline Investment Corp’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
2,975
-31
-1% -$10.6K 0.09% 64
2026
Q1
$1.06M Buy
3,006
+31
+1% +$11.1K 0.12% 64
2025
Q4
$974K Hold
2,975
0.11% 70
2025
Q3
$840K Hold
2,975
0.09% 77
2025
Q2
$831K Hold
2,975
0.09% 76
2025
Q1
$927K Hold
2,975
0.12% 65
2024
Q4
$775K Hold
2,975
0.09% 70
2024
Q3
$959K Hold
2,975
0.12% 62
2024
Q2
$930K Sell
2,975
-8,521
-74% -$2.5M 0.12% 58
2024
Q1
$3.27M Buy
11,496
+8,276
+257% +$2.42M 0.58% 38
2023
Q4
$927K Hold
3,220
0.15% 63
2023
Q3
$865K Hold
3,220
0.16% 63
2023
Q2
$715K Buy
3,220
+245
+8% +$56.8K 0.12% 70
2023
Q1
$719K Hold
2,975
0.14% 65
2022
Q4
$781K Buy
2,975
+1,934
+186% +$518K 0.18% 64
2022
Q3
$235K Sell
1,041
-8,359
-89% -$2.03M 0.19% 119
2022
Q2
$2.16M Buy
9,400
+198
+2% +$48.5K 0.31% 50
2022
Q1
$2.24M Buy
9,202
+2,858
+45% +$657K 0.28% 55
2021
Q4
$1.43M Sell
6,344
-1,668
-21% -$352K 0.2% 66
2021
Q3
$1.7M Sell
8,012
-1,190
-13% -$274K 0.24% 58
2021
Q2
$2.24M Hold
9,202
0.28% 55
2021
Q1
$2.29M Sell
9,202
-198
-2% -$47.2K 0.35% 47
2020
Q4
$2.16M Sell
9,400
-333
-3% -$76.8K 0.31% 50
2020
Q3
$2.47M Sell
9,733
-1,456
-13% -$361K 0.42% 41
2020
Q2
$2.64M Buy
11,189
+110
+1% +$25.1K 0.55% 38
2020
Q1
$2.25M Sell
11,079
-42
-0.4% -$9.17K 0.56% 35
2019
Q4
$2.68M Sell
11,121
-120
-1% -$26.5K 0.57% 34
2019
Q3
$2.17M Sell
11,241
-90
-0.8% -$17.3K 0.52% 42
2019
Q2
$2.09M Buy
11,331
+18
+0.2% +$3.22K 0.5% 42
2019
Q1
$2.15M Buy
11,313
+58
+0.5% +$11.1K 0.56% 35
2018
Q4
$2.19M Buy
11,255
+410
+4% +$80K 0.67% 31
2018
Q3
$2.25M Sell
10,845
-58
-0.5% -$11.4K 0.53% 45
2018
Q2
$2.01M Buy
10,903
+148
+1% +$26.2K 0.54% 43
2018
Q1
$1.83M Buy
10,755
+13
+0.1% +$2.39K 0.5% 47
2017
Q4
$1.87M Buy
10,742
+180
+2% +$31.9K 0.52% 49
2017
Q3
$1.97M Buy
10,562
+24
+0.2% +$4.25K 0.6% 45
2017
Q2
$1.81M Buy
10,538
+900
+9% +$146K 0.58% 47
2017
Q1
$1.58M Hold
9,638
0.51% 50
2016
Q4
$1.41M Sell
9,638
-2,685
-22% -$404K 0.49% 53
2016
Q3
$2.06M Hold
12,323
0.74% 37
2016
Q2
$1.88M Buy
12,323
+10
+0.1% +$1.55K 0.67% 38
2016
Q1
$1.85M Buy
12,313
+2,420
+24% +$360K 0.67% 36
2015
Q4
$1.61M Sell
9,893
-2,400
-20% -$377K 0.6% 41
2015
Q3
$1.7M Sell
12,293
-14,884
-55% -$2.35M 0.62% 39
2015
Q2
$4.17M Buy
27,177
+21
+0.1% +$3.36K 1.39% 21
2015
Q1
$4.34M Sell
27,156
-5,755
-17% -$906K 1.42% 20
2014
Q4
$5.24M Hold
32,911
1.75% 11
2014
Q3
$4.62M Buy
32,911
+30
+0.1% +$3.92K 1.66% 10
2014
Q2
$3.89M Sell
32,881
-4,570
-12% -$529K 1.4% 22
2014
Q1
$4.62M Hold
37,451
1.58% 16
2013
Q4
$4.27M Buy
37,451
+228
+0.6% +$25.9K 1.48% 19
2013
Q3
$4.17M Buy
37,223
+250
+0.7% +$27.1K 1.63% 15
2013
Q2
$3.65M Buy
+36,973
New +$3.84M 1.47% 17

Other funds holding AMGN

Hartline Investment Corp's AMGN Position: Q2 2026 in Review

Hartline Investment Corp reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $10.6K and leaving 2,975 shares worth $1.08M. The position accounts for 0.09% of the portfolio, ranked #64.

Hartline Investment Corp first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.24M in Q4 2014. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hartline Investment Corp held 2,975 shares of Amgen worth $1.08M as of Q2 2026.
  • Hartline Investment Corp sold 31 Amgen shares in Q2 2026, an estimated $10.6K.
  • Amgen made up 0.09% of Hartline Investment Corp's portfolio in Q2 2026, its #64 holding.
  • Hartline Investment Corp first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Hartline Investment Corp's Amgen position peaked at $5.24M in Q4 2014.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hartline Investment Corp's 13F filing for Q2 2026, filed 29 Jul 2026.